These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 10887156

  • 1. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.
    Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G.
    Genes Dev; 2000 Jul 01; 14(13):1617-30. PubMed ID: 10887156
    [Abstract] [Full Text] [Related]

  • 2. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA.
    Hum Mol Genet; 1994 Jan 01; 3(1):147-51. PubMed ID: 8162016
    [Abstract] [Full Text] [Related]

  • 3. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM.
    Hum Mol Genet; 1994 Jun 01; 3(6):885-91. PubMed ID: 7951231
    [Abstract] [Full Text] [Related]

  • 4. Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.
    Robanus-Maandag E, Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Antonescu C, Thomas G, Berns A.
    Oncogene; 2004 Aug 26; 23(39):6541-7. PubMed ID: 15221010
    [Abstract] [Full Text] [Related]

  • 5. Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.
    Castellanos E, Plana A, Carrato C, Carrió M, Rosas I, Amilibia E, Roca-Ribas F, Hostalot C, Castillo A, Ros A, Quer A, Becerra JL, Salvador H, Lázaro C, Blanco I, Serra E, Bielsa I, for CSUR Phakomatoses Multidisciplinary Clinics HUGTiP-ICO-IGTP.
    JAMA Dermatol; 2018 Mar 01; 154(3):341-346. PubMed ID: 29322178
    [Abstract] [Full Text] [Related]

  • 6. Frequency of the Loss of Heterozygosity of the NF2 Gene in Sporadic Spinal Schwannomas.
    DE Carvalho RM, DE Castro Sant' Anna C, Pinto GR, Paschoal EHA, Tuji FM, DO Nascimento Borges B, Soares PC, Júnior AGF, Rey JA, Chaves LCL, Burbano RR.
    Anticancer Res; 2018 Apr 01; 38(4):2149-2154. PubMed ID: 29599333
    [Abstract] [Full Text] [Related]

  • 7. Analysis of mutations in the SCH gene in schwannomas.
    Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ.
    Genes Chromosomes Cancer; 1994 Sep 01; 11(1):7-14. PubMed ID: 7529050
    [Abstract] [Full Text] [Related]

  • 8. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
    Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN.
    J Neuropathol Exp Neurol; 1998 Dec 01; 57(12):1164-7. PubMed ID: 9862639
    [Abstract] [Full Text] [Related]

  • 9. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
    Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF.
    Neurogenetics; 1999 Apr 01; 2(2):101-8. PubMed ID: 10369886
    [Abstract] [Full Text] [Related]

  • 10. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
    Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL, Giovannini M, McClatchey AI.
    Nat Commun; 2023 Mar 21; 14(1):1559. PubMed ID: 36944680
    [Abstract] [Full Text] [Related]

  • 11. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
    Castellanos E, Bielsa I, Carrato C, Rosas I, Solanes A, Hostalot C, Amilibia E, Prades J, Roca-Ribas F, Lázaro C, Blanco I, Serra E, NF2 Multidisciplinary Clinics HUGTiP-ICO-IMPPC.
    BMC Med Genomics; 2015 Jan 24; 8():2. PubMed ID: 25739810
    [Abstract] [Full Text] [Related]

  • 12. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
    Kehrer-Sawatzki H, Udart M, Krone W, Baden R, Fahsold R, Thomas G, Schmucker B, Assum G.
    Hum Genet; 1997 Jul 24; 100(1):67-74. PubMed ID: 9225971
    [Abstract] [Full Text] [Related]

  • 13. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG.
    Oncogene; 2010 Nov 25; 29(47):6216-21. PubMed ID: 20729918
    [Abstract] [Full Text] [Related]

  • 14. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
    Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X, Yuan J, Territo P, Hutchins G, Nalepa G, Yang FC, Conway SJ, Heinz MG, Stemmer-Rachamimov A, Yates CW, Wade Clapp D.
    Hum Mol Genet; 2015 Jan 01; 24(1):1-8. PubMed ID: 25113746
    [Abstract] [Full Text] [Related]

  • 15. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
    Sainz J, Figueroa K, Baser ME, Pulst SM.
    Hum Genet; 1996 Jan 01; 97(1):121-3. PubMed ID: 8557252
    [Abstract] [Full Text] [Related]

  • 16. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE, Bello MJ, Mendiola M, Kusak ME, De Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA.
    Int J Mol Med; 1998 May 01; 1(5):889-92. PubMed ID: 9852312
    [Abstract] [Full Text] [Related]

  • 17. A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected].
    Kluwe L, Pulst SM, Köppen J, Mautner VF.
    Hum Genet; 1995 Apr 01; 95(4):443-6. PubMed ID: 7705843
    [Abstract] [Full Text] [Related]

  • 18. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
    Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D.
    Cancer Genet Cytogenet; 2000 Apr 15; 118(2):167-8. PubMed ID: 10748301
    [Abstract] [Full Text] [Related]

  • 19. The importance of nerve microenvironment for schwannoma development.
    Schulz A, Büttner R, Hagel C, Baader SL, Kluwe L, Salamon J, Mautner VF, Mindos T, Parkinson DB, Gehlhausen JR, Clapp DW, Morrison H.
    Acta Neuropathol; 2016 Aug 15; 132(2):289-307. PubMed ID: 27236462
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.